日本ケミファ(株)の貸借残高情報
| 主市場 | 業種 | 証券コード/EDINET | 英名称 |
|---|---|---|---|
| 東証STD | 医薬品 | 4539/E00957 | NIPPON CHEMIPHAR CO., LTD. |
| 公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
|---|---|---|---|---|---|---|---|---|---|
| 2022/05/27 | 日証協 | 11,164株 | +3.41% | 1,443株 | -61% | 41,088株 | +1.76% | 3,911株 | -31.97% |
| 2022/05/20 | 日証協 | 10,796株 | +14.9% | 3,700株 | -22.92% | 40,379株 | +6.04% | 5,749株 | -34.16% |
| 2022/05/13 | 日証協 | 9,396株 | +25.35% | 4,800株 | +1100% | 38,080株 | +13.57% | 8,732株 | +853.28% |
| 2022/05/06 | 日証協 | 7,496株 | -2.6% | 400株 | -63.64% | 33,529株 | +4.36% | 916株 | -83.28% |
| 2022/04/28 | 日証協 | 7,696株 | +14.93% | 1,100株 | +175% | 32,128株 | +8.08% | 5,480株 | +107.97% |
| 2022/04/22 | 日証協 | 6,696株 | +3.08% | 400株 | +300% | 29,725株 | +4.94% | 2,635株 | +285.23% |
| 2022/04/15 | 日証協 | 6,496株 | -15.58% | 100株 | -91.69% | 28,325株 | 0% | 684株 | -73.06% |
| 2022/04/08 | 日証協 | 7,695株 | -9.42% | 1,204株 | +20.4% | 28,325株 | -5.02% | 2,539株 | -88.34% |
| 2022/04/01 | 日証協 | 8,495株 | -39.43% | 1,000株 | -41.31% | 29,823株 | -16.12% | 21,769株 | +238.66% |
| 2022/03/25 | 日証協 | 14,026株 | +8.81% | 1,704株 | -31.84% | 35,554株 | +17.25% | 6,428株 | +184.42% |
| 2022/03/18 | 日証協 | 12,890株 | +5.47% | 2,500株 | +2400% | 30,322株 | -0.66% | 2,260株 | 0% |
| 2022/03/11 | 日証協 | 12,222株 | -9.45% | 100株 | 0% | 30,522株 | -2.88% | 0株 | -100% |
| 2022/03/04 | 日証協 | 13,498株 | -6.81% | 0株 | -100% | 31,427株 | +6.8% | 4,188株 | +101.83% |
| 2022/02/25 | 日証協 | 14,485株 | -2.12% | 774株 | +31.86% | 29,427株 | -6.69% | 2,075株 | -1.43% |
| 2022/02/18 | 日証協 | 14,798株 | -19.62% | 587株 | -26.62% | 31,537株 | -10.51% | 2,105株 | -54.86% |
| 2022/02/10 | 日証協 | 18,411株 | -1.6% | 800株 | 0% | 35,240株 | +0.02% | 4,663株 | +27.47% |
| 2022/02/04 | 日証協 | 18,711株 | -8.63% | 800株 | -63.74% | 35,234株 | -3.02% | 3,658株 | +17.89% |
| 2022/01/28 | 日証協 | 20,479株 | +3.61% | 2,206株 | +185.01% | 36,333株 | +1.4% | 3,103株 | -49.4% |
| 2022/01/21 | 日証協 | 19,766株 | -3.42% | 774株 | -21.58% | 35,833株 | +2.29% | 6,132株 | +788.7% |
※株式分割は考慮していませんのでご注意ください。